1415 related articles for article (PubMed ID: 20211727)
1. Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(D, L-lactide) (PLA) based nanoparticles.
Essa S; Rabanel JM; Hildgen P
Eur J Pharm Biopharm; 2010 Jun; 75(2):96-106. PubMed ID: 20211727
[TBL] [Abstract][Full Text] [Related]
2. Effect of aqueous solubility of grafted moiety on the physicochemical properties of poly(d,l-lactide) (PLA) based nanoparticles.
Essa S; Rabanel JM; Hildgen P
Int J Pharm; 2010 Mar; 388(1-2):263-73. PubMed ID: 20060450
[TBL] [Abstract][Full Text] [Related]
3. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
Sant S; Poulin S; Hildgen P
J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
[TBL] [Abstract][Full Text] [Related]
4. Improved antifungal activity of itraconazole-loaded PEG/PLA nanoparticles.
Essa S; Louhichi F; Raymond M; Hildgen P
J Microencapsul; 2013; 30(3):205-17. PubMed ID: 22894166
[TBL] [Abstract][Full Text] [Related]
5. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
Essa S; Rabanel JM; Hildgen P
Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
[TBL] [Abstract][Full Text] [Related]
6. Microporous structure and drug release kinetics of polymeric nanoparticles.
Sant S; Thommes M; Hildgen P
Langmuir; 2008 Jan; 24(1):280-7. PubMed ID: 18052222
[TBL] [Abstract][Full Text] [Related]
7. Effect of the Polymer Architecture on the Structural and Biophysical Properties of PEG-PLA Nanoparticles.
Rabanel JM; Faivre J; Tehrani SF; Lalloz A; Hildgen P; Banquy X
ACS Appl Mater Interfaces; 2015 May; 7(19):10374-85. PubMed ID: 25909493
[TBL] [Abstract][Full Text] [Related]
8. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
[TBL] [Abstract][Full Text] [Related]
9. Tablet formulation of Famotidine-loaded P-gp inhibiting nanoparticles using PLA-g-PEG grafted polymer.
Mokhtar M; Gosselin PM; François-Xavier L; Hildgen P
Pharm Dev Technol; 2019 Feb; 24(2):211-221. PubMed ID: 29564944
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles of poly(D,L-lactide)/methoxy poly(ethylene glycol)-poly(D,L-lactide) blends for controlled release of paclitaxel.
Dong Y; Feng SS
J Biomed Mater Res A; 2006 Jul; 78(1):12-9. PubMed ID: 16596586
[TBL] [Abstract][Full Text] [Related]
11. Design of PEG-grafted-PLA nanoparticles as oral permeability enhancer for P-gp substrate drug model Famotidine.
Mokhtar M; Gosselin P; Lacasse F; Hildgen P
J Microencapsul; 2017 Feb; 34(1):91-103. PubMed ID: 28151040
[TBL] [Abstract][Full Text] [Related]
12. Novel multi-biotin grafted poly(lactic acid) and its self-assembling nanoparticles capable of binding to streptavidin.
Yan H; Jiang W; Zhang Y; Liu Y; Wang B; Yang L; Deng L; Singh GK; Pan J
Int J Nanomedicine; 2012; 7():457-65. PubMed ID: 22334778
[TBL] [Abstract][Full Text] [Related]
13. Intranasal delivery of zidovudine by PLA and PLA-PEG blend nanoparticles.
Mainardes RM; Khalil NM; Gremião MP
Int J Pharm; 2010 Aug; 395(1-2):266-71. PubMed ID: 20580792
[TBL] [Abstract][Full Text] [Related]
14. Mitomycin C-soybean phosphatidylcholine complex-loaded self-assembled PEG-lipid-PLA hybrid nanoparticles for targeted drug delivery and dual-controlled drug release.
Li Y; Wu H; Yang X; Jia M; Li Y; Huang Y; Lin J; Wu S; Hou Z
Mol Pharm; 2014 Aug; 11(8):2915-27. PubMed ID: 24984984
[TBL] [Abstract][Full Text] [Related]
15. Preparation, optimization and in vitro characterization of stearoyl-gemcitabine polymeric micelles: a comparison with its self-assembled nanoparticles.
Daman Z; Ostad S; Amini M; Gilani K
Int J Pharm; 2014 Jul; 468(1-2):142-51. PubMed ID: 24731731
[TBL] [Abstract][Full Text] [Related]
16. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
[TBL] [Abstract][Full Text] [Related]
17. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
18. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Jun; 30(16):3009-19. PubMed ID: 19250665
[TBL] [Abstract][Full Text] [Related]
19. Preparation of nanoparticles consisted of poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) and their evaluation in vitro.
Matsumoto J; Nakada Y; Sakurai K; Nakamura T; Takahashi Y
Int J Pharm; 1999 Aug; 185(1):93-101. PubMed ID: 10425369
[TBL] [Abstract][Full Text] [Related]
20. PLA-PEG-PLA copolymer-based polymersomes as nanocarriers for delivery of hydrophilic and hydrophobic drugs: preparation and evaluation with atorvastatin and lisinopril.
Danafar H; Rostamizadeh K; Davaran S; Hamidi M
Drug Dev Ind Pharm; 2014 Oct; 40(10):1411-20. PubMed ID: 23944838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
